World Health Organization (WHO) said that a number of treatments are under clinical trials for the treatment of COVID-19

Geneva: The World Health Organization (WHO) said that a number of treatments are under clinical trials for the treatment of COVID-19, but none of those were yet approved.
“There are hundreds of clinical trials that are underway, and the reason we need to wait for the results of these studies is because they are evaluating how these medicines, how these drugs work, in terms of either preventing infection, preventing someone from progressing to severe disease, preventing death and how safe they are, do they have any side effects,” Maria Van Kerkhove, technical lead for the WHO’s Health Emergencies Program, said on Friday in a press conference in Geneva, Xinhua news agency reported.

“Right now, WHO has launched the ‘Solidarity Trial’ which is a clinical trial focusing on some drugs, some therapeutics, to look at whether or not these are safe and effective for COVID-19. There are more than 2,500 patients enrolled in this multi-site clinical trial,” she said.
“And it will take some time before we have full answers to which treatments work, but right now we don’t have any approved treatments for COVID-19.” she added.
Michael Ryan, executive director of the WHO Health Emergencies Program, stressed the importance of proper process to ensure safety.
“And there’s a very very well tested process of doing this, so it’s really important that we encourage innovation, we encourage people to be looking for solutions, but then as those solutions potentially become available, we need to put them through the proper process in the interest of safety, in the interest of efficacy and in order to make sure that we first do no harm,” he said.

CU Denver receives UGC letter of intent for Hyderabad campus, first cohort to start in 2027

NIRF 2026 Faces Retraction Test as India Tightens Scrutiny of Research Quality

IIM Ahmedabad revises PGP shortlisting criteria for CAT 2026

BPSC 72nd Prelims postponed again, fresh exam date awaited

16-year-old Belgian prodigy pursues second PhD after quantum physics doctorate

16-year-old Belgian prodigy pursues second PhD after quantum physics doctorate

Jeff Bezos-backed Bezos Academy opens largest preschool in Texas

IIT Bombay may put one-semester suspension rule for exam malpractice on hold

UWA Chennai campus faces opposition from Tamil Nadu teachers and CPI(M)

ISB to award 250 scholarships every year with tuition waivers up to 100%

CU Denver receives UGC letter of intent for Hyderabad campus, first cohort to start in 2027

NIRF 2026 Faces Retraction Test as India Tightens Scrutiny of Research Quality

IIM Ahmedabad revises PGP shortlisting criteria for CAT 2026

BPSC 72nd Prelims postponed again, fresh exam date awaited

16-year-old Belgian prodigy pursues second PhD after quantum physics doctorate

16-year-old Belgian prodigy pursues second PhD after quantum physics doctorate

Jeff Bezos-backed Bezos Academy opens largest preschool in Texas

IIT Bombay may put one-semester suspension rule for exam malpractice on hold

UWA Chennai campus faces opposition from Tamil Nadu teachers and CPI(M)

ISB to award 250 scholarships every year with tuition waivers up to 100%
Copyright© educationpost.in 2024 All Rights Reserved.
Designed and Developed by @Pyndertech